Immunopotentiators in modern vaccines:
Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Academic Press
[2017]
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Online-Zugang: | FAW01 URL des Erstveröffentlichers URL des Erstveröffentlichers |
| Zusammenfassung: | Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the subject, the chapters here provide summaries of key data on the mechanisms of action of the individual vaccine adjuvants. In addition, the book covers key aspects of how the technologies might be further developed and what might be their limitations, while also giving an overview of what made the most advanced adjuvant technologies successful. Provides contributions from leading international authorities in the field; features immunopotentiators classified by function, with well-illustrated, informative figures presenting the interaction between the immunopotentiators and the host immune system; lists advantages and potential hurdles for achieving a practical application for each specific immunopotentiator; offers US FDA perspectives which highlight how future adjuvants will be approved for new generation vaccines |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | 1 online resource (xvii, 490 pages) illustrations |
| ISBN: | 9780128040195 012804019X 9780128040959 0128040955 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045382086 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181228s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9780128040195 |9 978-0-12-804019-5 | ||
| 020 | |a 012804019X |9 0-12-804019-X | ||
| 020 | |a 9780128040959 |9 978-0-12-804095-9 | ||
| 020 | |a 0128040955 |9 0-12-804095-5 | ||
| 035 | |a (ZDB-33-ESD)ocn963184312 | ||
| 035 | |a (ZDB-33-EBS)ocn963184312 | ||
| 035 | |a (OCoLC)963184312 | ||
| 035 | |a (DE-599)BVBBV045382086 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615.372 |2 22 | |
| 245 | 1 | 0 | |a Immunopotentiators in modern vaccines |c Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States |
| 250 | |a Second edition | ||
| 264 | 1 | |a Amsterdam |b Academic Press |c [2017] | |
| 264 | 4 | |c © 2017 | |
| 300 | |a 1 online resource (xvii, 490 pages) |b illustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 520 | |a Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the subject, the chapters here provide summaries of key data on the mechanisms of action of the individual vaccine adjuvants. In addition, the book covers key aspects of how the technologies might be further developed and what might be their limitations, while also giving an overview of what made the most advanced adjuvant technologies successful. Provides contributions from leading international authorities in the field; features immunopotentiators classified by function, with well-illustrated, informative figures presenting the interaction between the immunopotentiators and the host immune system; lists advantages and potential hurdles for achieving a practical application for each specific immunopotentiator; offers US FDA perspectives which highlight how future adjuvants will be approved for new generation vaccines | ||
| 650 | 4 | |a Vaccines / immunology | |
| 650 | 4 | |a Adjuvants, Immunocologic | |
| 650 | 4 | |a Drug Delivery Systems | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 7 | |a Immune response / Regulation |2 fast | |
| 650 | 7 | |a Immunological adjuvants |2 fast | |
| 650 | 7 | |a Vaccines |2 fast | |
| 650 | 4 | |a Immunological adjuvants | |
| 650 | 4 | |a Immune response |x Regulation | |
| 650 | 4 | |a Vaccines | |
| 700 | 1 | |a Schijns, Virgil |4 edt | |
| 700 | 1 | |a O'Hagan, Derek |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 0120884038 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 0080457215 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 661063047X |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 1280630477 |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780128040195 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/book/9780128040195 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030768419 | ||
| 966 | e | |u http://www.sciencedirect.com/science/book/9780128040195 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804179233578156032 |
|---|---|
| any_adam_object | |
| author2 | Schijns, Virgil O'Hagan, Derek |
| author2_role | edt edt |
| author2_variant | v s vs d o do |
| author_facet | Schijns, Virgil O'Hagan, Derek |
| building | Verbundindex |
| bvnumber | BV045382086 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (ZDB-33-ESD)ocn963184312 (ZDB-33-EBS)ocn963184312 (OCoLC)963184312 (DE-599)BVBBV045382086 |
| dewey-full | 615.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.372 |
| dewey-search | 615.372 |
| dewey-sort | 3615.372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Second edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03429nmm a2200601zc 4500</leader><controlfield tag="001">BV045382086</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181228s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128040195</subfield><subfield code="9">978-0-12-804019-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">012804019X</subfield><subfield code="9">0-12-804019-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128040959</subfield><subfield code="9">978-0-12-804095-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128040955</subfield><subfield code="9">0-12-804095-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn963184312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-EBS)ocn963184312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)963184312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045382086</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.372</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunopotentiators in modern vaccines</subfield><subfield code="c">Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Academic Press</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvii, 490 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the subject, the chapters here provide summaries of key data on the mechanisms of action of the individual vaccine adjuvants. In addition, the book covers key aspects of how the technologies might be further developed and what might be their limitations, while also giving an overview of what made the most advanced adjuvant technologies successful. Provides contributions from leading international authorities in the field; features immunopotentiators classified by function, with well-illustrated, informative figures presenting the interaction between the immunopotentiators and the host immune system; lists advantages and potential hurdles for achieving a practical application for each specific immunopotentiator; offers US FDA perspectives which highlight how future adjuvants will be approved for new generation vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines / immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adjuvants, Immunocologic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immune response / Regulation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunological adjuvants</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccines</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunological adjuvants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune response</subfield><subfield code="x">Regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schijns, Virgil</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Hagan, Derek</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">0120884038</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">0080457215</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">661063047X</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">1280630477</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780128040195</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.sciencedirect.com/science/book/9780128040195</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030768419</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780128040195</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV045382086 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:16:37Z |
| institution | BVB |
| isbn | 9780128040195 012804019X 9780128040959 0128040955 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030768419 |
| oclc_num | 963184312 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 online resource (xvii, 490 pages) illustrations |
| psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Immunopotentiators in modern vaccines Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States Second edition Amsterdam Academic Press [2017] © 2017 1 online resource (xvii, 490 pages) illustrations txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the subject, the chapters here provide summaries of key data on the mechanisms of action of the individual vaccine adjuvants. In addition, the book covers key aspects of how the technologies might be further developed and what might be their limitations, while also giving an overview of what made the most advanced adjuvant technologies successful. Provides contributions from leading international authorities in the field; features immunopotentiators classified by function, with well-illustrated, informative figures presenting the interaction between the immunopotentiators and the host immune system; lists advantages and potential hurdles for achieving a practical application for each specific immunopotentiator; offers US FDA perspectives which highlight how future adjuvants will be approved for new generation vaccines Vaccines / immunology Adjuvants, Immunocologic Drug Delivery Systems Immunotherapy Immune response / Regulation fast Immunological adjuvants fast Vaccines fast Immunological adjuvants Immune response Regulation Vaccines Schijns, Virgil edt O'Hagan, Derek edt Erscheint auch als Druck-Ausgabe 0120884038 Erscheint auch als Druck-Ausgabe 0080457215 Erscheint auch als Druck-Ausgabe 661063047X Erscheint auch als Druck-Ausgabe 1280630477 http://www.sciencedirect.com/science/book/9780128040195 Verlag URL des Erstveröffentlichers Volltext https://www.sciencedirect.com/science/book/9780128040195 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Immunopotentiators in modern vaccines Vaccines / immunology Adjuvants, Immunocologic Drug Delivery Systems Immunotherapy Immune response / Regulation fast Immunological adjuvants fast Vaccines fast Immunological adjuvants Immune response Regulation Vaccines |
| title | Immunopotentiators in modern vaccines |
| title_auth | Immunopotentiators in modern vaccines |
| title_exact_search | Immunopotentiators in modern vaccines |
| title_full | Immunopotentiators in modern vaccines Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States |
| title_fullStr | Immunopotentiators in modern vaccines Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States |
| title_full_unstemmed | Immunopotentiators in modern vaccines Virgil Schijns, Wageningen University, Wageningen, the Netherlands ; Derek O'Hagan, GSK Vaccines, Rockville MD, United States |
| title_short | Immunopotentiators in modern vaccines |
| title_sort | immunopotentiators in modern vaccines |
| topic | Vaccines / immunology Adjuvants, Immunocologic Drug Delivery Systems Immunotherapy Immune response / Regulation fast Immunological adjuvants fast Vaccines fast Immunological adjuvants Immune response Regulation Vaccines |
| topic_facet | Vaccines / immunology Adjuvants, Immunocologic Drug Delivery Systems Immunotherapy Immune response / Regulation Immunological adjuvants Vaccines Immune response Regulation |
| url | http://www.sciencedirect.com/science/book/9780128040195 https://www.sciencedirect.com/science/book/9780128040195 |
| work_keys_str_mv | AT schijnsvirgil immunopotentiatorsinmodernvaccines AT ohaganderek immunopotentiatorsinmodernvaccines |